{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Are you looking for a stock?

Try one of these

{{result.description}}
{{result.ric}}
More Results

BNN

Scoreboard

    BNN

    Most Popular Content

    Latest Videos

    {{ currentStream.Name }}

    Related Video

    Continuous Play:
    ON OFF

    The information you requested is not available at this time, please check back again soon.

    More Video

    Dec 8, 2017

    Teva considering cutting up to 10,000 jobs: Report

    Akankshita Mukhopadhyay, Reuters

    Teva Pharmaceutical Industries Jerusalem Feb. 8 2017

    The logo of Teva Pharmaceutical Industries, the world's biggest generic drugmaker and Israel's largest company, is seen in Jerusalem February 8, 2017 , Reuters/Ronen Zvulun

    Security Not Found

    The stock symbol {{StockChart.Ric}} does not exist

    See Full Stock Page »

    Teva Pharmaceutical Industries Ltd (TEVA.N), the world's largest maker of generic drugs, is considering cutting up to 10,000 jobs, Bloomberg News reported on Friday.

    Israel-based Teva wants to cut costs by US$1.5 billion to US$2 billion over the next two years, Bloomberg said, citing people with knowledge of the matter.